TS
THC icon

Thomas Steyer’s Tenet Healthcare THC Stock Holding History

Thomas Steyer’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-452,153
Closed -$85.3M – 178
2026
Q1 		$85.3M Buy
452,153
+80,000
+21% +$16.9M 0.45% 36
2025
Q4 		$74M Sell
372,153
-41,847
-10% -$8.46M 0.32% 50
2025
Q3 		$84.1M Sell
414,000
-115,000
-22% -$20.4M 0.34% 48
2025
Q2 		$93.1M Buy
+529,000
New +$79.6M 0.39% 46
2024
Q4 		– Sell
-692,442
Closed -$115M – 171
2024
Q3 		$115M Buy
692,442
+5,000
+0.7% +$756K 0.5% 51
2024
Q2 		$91.5M Buy
687,442
+50,000
+8% +$6.02M 0.39% 49
2024
Q1 		$67M Buy
637,442
+262,600
+70% +$23.6M 0.28% 52
2023
Q4 		$28.3M Sell
374,842
-655,158
-64% -$41.5M 0.13% 64
2023
Q3 		$67.9M Buy
1,030,000
+278,000
+37% +$20.8M 0.32% 55
2023
Q2 		$61.2M Buy
752,000
+363,000
+93% +$25.8M 0.31% 61
2023
Q1 		$23.1M Buy
+389,000
New +$21.6M 0.13% 77

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Thomas Steyer's THC Position: Q2 2026 in Review

Thomas Steyer sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 452,153 shares — an estimated $85.3M sold.

Thomas Steyer first reported a position in THC in Q1 2023 and held it in 11 quarters. The position peaked at $115M in Q3 2024. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Thomas Steyer reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Thomas Steyer sold 452,153 Tenet Healthcare shares in Q2 2026, an estimated $85.3M.
  • Thomas Steyer first reported a position in Tenet Healthcare in Q1 2023 and held it in 11 quarters.
  • Thomas Steyer's Tenet Healthcare position peaked at $115M in Q3 2024.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.